Robocath Updates Progress With R-One Robotic Coronary Intervention Platform

 
• By Reed Miller

French company Robocath believes its R-One robotic catheter intervention system will make coronary interventions more efficient for hospitals and safer for interventionalists. Robocath is sponsoring a 60-patient European trial of coronary interventions with R-One.

Robocath Angioplasties, South Africa
Faizel Lorgat performs a coronary intervention with Robocath's R-One platform at Netcare Christiaan Barnard Memorial Hospital in Cape Town, South Africa.

More from Clinical Trials

More from R&D